About Us Services Careers FAQ Contact Us 0
Home Healthcare IT Enzyme Replacement Therapy Market Size, Share and Forecast to 2031

Enzyme Replacement Therapy Market

Enzyme Replacement Therapy Market: Information by Product (Agalsidase Beta, Imiglucerase, Velaglucerase Alfa), Disease (Gaucher Disease, Mucopolysaccharidosis, (EPI)), End-User (Hospitals and Infusion Centers), and Regions—Forecast Till 2031

The global enzyme replacement therapy market size was valued at USD 8.57 billion in 2022. It is projected to reach USD 17.06 billion by 2031, growing at a CAGR of 8.98% during the forecast period (2023-2031). Enzyme replacement therapy is a type of
Report Code: SRHI54773DR
Buy Now
File Formats

Market Segmentation

  1. Enzyme Replacement Therapy Market, By Product (2021-2031)
    1. Agalsidase Beta
    2. Imiglucerase
    3. Velaglucerase Alfa
    4. Idursulfase
    5. Galsulfase
    6. Laronidase
    7. Others
  2. Enzyme Replacement Therapy Market, By Disease (2021-2031)
    1. Gaucher Disease
    2. Fabry Disease
    3. Pompe Disease
    4. Mucopolysaccharidosis
    5. Exocrine Pancreatic Insufficiency (EPI)
    6. Others
  3. Enzyme Replacement Therapy Market, By End-User (2021-2031)
    1. Hospitals
    2. Infusion Centers and Home Healthcare Setting
    1. North America
      1. North America Enzyme Replacement Therapy Market, By Product
        1. Agalsidase Beta
          1. Imiglucerase
            1. Velaglucerase Alfa
              1. Idursulfase
                1. Galsulfase
                  1. Laronidase
                    1. Others
                    2. North America Enzyme Replacement Therapy Market, By Disease
                      1. Gaucher Disease
                        1. Fabry Disease
                          1. Pompe Disease
                            1. Mucopolysaccharidosis
                              1. Exocrine Pancreatic Insufficiency (EPI)
                                1. Others
                                2. North America Enzyme Replacement Therapy Market, By End-User
                                  1. Hospitals
                                    1. Infusion Centers and Home Healthcare Setting
                                    2. U.S.
                                      1. U.S. Enzyme Replacement Therapy Market, By Product
                                        1. Agalsidase Beta
                                          1. Imiglucerase
                                            1. Velaglucerase Alfa
                                              1. Idursulfase
                                                1. Galsulfase
                                                  1. Laronidase
                                                    1. Others
                                                    2. U.S. Enzyme Replacement Therapy Market, By Disease
                                                      1. Gaucher Disease
                                                        1. Fabry Disease
                                                          1. Pompe Disease
                                                            1. Mucopolysaccharidosis
                                                              1. Exocrine Pancreatic Insufficiency (EPI)
                                                                1. Others
                                                                2. U.S. Enzyme Replacement Therapy Market, By End-User
                                                                  1. Hospitals
                                                                    1. Infusion Centers and Home Healthcare Setting
                                                                  2. Canada
                                                                3. Europe
                                                                  1. Europe Enzyme Replacement Therapy Market, By Product
                                                                    1. Agalsidase Beta
                                                                      1. Imiglucerase
                                                                        1. Velaglucerase Alfa
                                                                          1. Idursulfase
                                                                            1. Galsulfase
                                                                              1. Laronidase
                                                                                1. Others
                                                                                2. Europe Enzyme Replacement Therapy Market, By Disease
                                                                                  1. Gaucher Disease
                                                                                    1. Fabry Disease
                                                                                      1. Pompe Disease
                                                                                        1. Mucopolysaccharidosis
                                                                                          1. Exocrine Pancreatic Insufficiency (EPI)
                                                                                            1. Others
                                                                                            2. Europe Enzyme Replacement Therapy Market, By End-User
                                                                                              1. Hospitals
                                                                                                1. Infusion Centers and Home Healthcare Setting
                                                                                                2. U.K.
                                                                                                  1. U.K. Enzyme Replacement Therapy Market, By Product
                                                                                                    1. Agalsidase Beta
                                                                                                      1. Imiglucerase
                                                                                                        1. Velaglucerase Alfa
                                                                                                          1. Idursulfase
                                                                                                            1. Galsulfase
                                                                                                              1. Laronidase
                                                                                                                1. Others
                                                                                                                2. U.K. Enzyme Replacement Therapy Market, By Disease
                                                                                                                  1. Gaucher Disease
                                                                                                                    1. Fabry Disease
                                                                                                                      1. Pompe Disease
                                                                                                                        1. Mucopolysaccharidosis
                                                                                                                          1. Exocrine Pancreatic Insufficiency (EPI)
                                                                                                                            1. Others
                                                                                                                            2. U.K. Enzyme Replacement Therapy Market, By End-User
                                                                                                                              1. Hospitals
                                                                                                                                1. Infusion Centers and Home Healthcare Setting
                                                                                                                              2. Germany
                                                                                                                              3. France
                                                                                                                              4. Spain
                                                                                                                              5. Italy
                                                                                                                              6. Russia
                                                                                                                              7. Nordic
                                                                                                                              8. Benelux
                                                                                                                              9. Rest of Europe
                                                                                                                            3. APAC
                                                                                                                              1. APAC Enzyme Replacement Therapy Market, By Product
                                                                                                                                1. Agalsidase Beta
                                                                                                                                  1. Imiglucerase
                                                                                                                                    1. Velaglucerase Alfa
                                                                                                                                      1. Idursulfase
                                                                                                                                        1. Galsulfase
                                                                                                                                          1. Laronidase
                                                                                                                                            1. Others
                                                                                                                                            2. APAC Enzyme Replacement Therapy Market, By Disease
                                                                                                                                              1. Gaucher Disease
                                                                                                                                                1. Fabry Disease
                                                                                                                                                  1. Pompe Disease
                                                                                                                                                    1. Mucopolysaccharidosis
                                                                                                                                                      1. Exocrine Pancreatic Insufficiency (EPI)
                                                                                                                                                        1. Others
                                                                                                                                                        2. APAC Enzyme Replacement Therapy Market, By End-User
                                                                                                                                                          1. Hospitals
                                                                                                                                                            1. Infusion Centers and Home Healthcare Setting
                                                                                                                                                            2. China
                                                                                                                                                              1. China Enzyme Replacement Therapy Market, By Product
                                                                                                                                                                1. Agalsidase Beta
                                                                                                                                                                  1. Imiglucerase
                                                                                                                                                                    1. Velaglucerase Alfa
                                                                                                                                                                      1. Idursulfase
                                                                                                                                                                        1. Galsulfase
                                                                                                                                                                          1. Laronidase
                                                                                                                                                                            1. Others
                                                                                                                                                                            2. China Enzyme Replacement Therapy Market, By Disease
                                                                                                                                                                              1. Gaucher Disease
                                                                                                                                                                                1. Fabry Disease
                                                                                                                                                                                  1. Pompe Disease
                                                                                                                                                                                    1. Mucopolysaccharidosis
                                                                                                                                                                                      1. Exocrine Pancreatic Insufficiency (EPI)
                                                                                                                                                                                        1. Others
                                                                                                                                                                                        2. China Enzyme Replacement Therapy Market, By End-User
                                                                                                                                                                                          1. Hospitals
                                                                                                                                                                                            1. Infusion Centers and Home Healthcare Setting
                                                                                                                                                                                          2. Korea
                                                                                                                                                                                          3. Japan
                                                                                                                                                                                          4. India
                                                                                                                                                                                          5. Australia
                                                                                                                                                                                          6. Taiwan
                                                                                                                                                                                          7. South East Asia
                                                                                                                                                                                          8. Rest of Asia-Pacific
                                                                                                                                                                                        3. Middle East and Africa
                                                                                                                                                                                          1. Middle East and Africa Enzyme Replacement Therapy Market, By Product
                                                                                                                                                                                            1. Agalsidase Beta
                                                                                                                                                                                              1. Imiglucerase
                                                                                                                                                                                                1. Velaglucerase Alfa
                                                                                                                                                                                                  1. Idursulfase
                                                                                                                                                                                                    1. Galsulfase
                                                                                                                                                                                                      1. Laronidase
                                                                                                                                                                                                        1. Others
                                                                                                                                                                                                        2. Middle East and Africa Enzyme Replacement Therapy Market, By Disease
                                                                                                                                                                                                          1. Gaucher Disease
                                                                                                                                                                                                            1. Fabry Disease
                                                                                                                                                                                                              1. Pompe Disease
                                                                                                                                                                                                                1. Mucopolysaccharidosis
                                                                                                                                                                                                                  1. Exocrine Pancreatic Insufficiency (EPI)
                                                                                                                                                                                                                    1. Others
                                                                                                                                                                                                                    2. Middle East and Africa Enzyme Replacement Therapy Market, By End-User
                                                                                                                                                                                                                      1. Hospitals
                                                                                                                                                                                                                        1. Infusion Centers and Home Healthcare Setting
                                                                                                                                                                                                                        2. UAE
                                                                                                                                                                                                                          1. UAE Enzyme Replacement Therapy Market, By Product
                                                                                                                                                                                                                            1. Agalsidase Beta
                                                                                                                                                                                                                              1. Imiglucerase
                                                                                                                                                                                                                                1. Velaglucerase Alfa
                                                                                                                                                                                                                                  1. Idursulfase
                                                                                                                                                                                                                                    1. Galsulfase
                                                                                                                                                                                                                                      1. Laronidase
                                                                                                                                                                                                                                        1. Others
                                                                                                                                                                                                                                        2. UAE Enzyme Replacement Therapy Market, By Disease
                                                                                                                                                                                                                                          1. Gaucher Disease
                                                                                                                                                                                                                                            1. Fabry Disease
                                                                                                                                                                                                                                              1. Pompe Disease
                                                                                                                                                                                                                                                1. Mucopolysaccharidosis
                                                                                                                                                                                                                                                  1. Exocrine Pancreatic Insufficiency (EPI)
                                                                                                                                                                                                                                                    1. Others
                                                                                                                                                                                                                                                    2. UAE Enzyme Replacement Therapy Market, By End-User
                                                                                                                                                                                                                                                      1. Hospitals
                                                                                                                                                                                                                                                        1. Infusion Centers and Home Healthcare Setting
                                                                                                                                                                                                                                                      2. Turkey
                                                                                                                                                                                                                                                      3. Saudi Arabia
                                                                                                                                                                                                                                                      4. South Africa
                                                                                                                                                                                                                                                      5. Egypt
                                                                                                                                                                                                                                                      6. Nigeria
                                                                                                                                                                                                                                                      7. Rest of MEA
                                                                                                                                                                                                                                                    3. LATAM
                                                                                                                                                                                                                                                      1. LATAM Enzyme Replacement Therapy Market, By Product
                                                                                                                                                                                                                                                        1. Agalsidase Beta
                                                                                                                                                                                                                                                          1. Imiglucerase
                                                                                                                                                                                                                                                            1. Velaglucerase Alfa
                                                                                                                                                                                                                                                              1. Idursulfase
                                                                                                                                                                                                                                                                1. Galsulfase
                                                                                                                                                                                                                                                                  1. Laronidase
                                                                                                                                                                                                                                                                    1. Others
                                                                                                                                                                                                                                                                    2. LATAM Enzyme Replacement Therapy Market, By Disease
                                                                                                                                                                                                                                                                      1. Gaucher Disease
                                                                                                                                                                                                                                                                        1. Fabry Disease
                                                                                                                                                                                                                                                                          1. Pompe Disease
                                                                                                                                                                                                                                                                            1. Mucopolysaccharidosis
                                                                                                                                                                                                                                                                              1. Exocrine Pancreatic Insufficiency (EPI)
                                                                                                                                                                                                                                                                                1. Others
                                                                                                                                                                                                                                                                                2. LATAM Enzyme Replacement Therapy Market, By End-User
                                                                                                                                                                                                                                                                                  1. Hospitals
                                                                                                                                                                                                                                                                                    1. Infusion Centers and Home Healthcare Setting
                                                                                                                                                                                                                                                                                    2. Brazil
                                                                                                                                                                                                                                                                                      1. Brazil Enzyme Replacement Therapy Market, By Product
                                                                                                                                                                                                                                                                                        1. Agalsidase Beta
                                                                                                                                                                                                                                                                                          1. Imiglucerase
                                                                                                                                                                                                                                                                                            1. Velaglucerase Alfa
                                                                                                                                                                                                                                                                                              1. Idursulfase
                                                                                                                                                                                                                                                                                                1. Galsulfase
                                                                                                                                                                                                                                                                                                  1. Laronidase
                                                                                                                                                                                                                                                                                                    1. Others
                                                                                                                                                                                                                                                                                                    2. Brazil Enzyme Replacement Therapy Market, By Disease
                                                                                                                                                                                                                                                                                                      1. Gaucher Disease
                                                                                                                                                                                                                                                                                                        1. Fabry Disease
                                                                                                                                                                                                                                                                                                          1. Pompe Disease
                                                                                                                                                                                                                                                                                                            1. Mucopolysaccharidosis
                                                                                                                                                                                                                                                                                                              1. Exocrine Pancreatic Insufficiency (EPI)
                                                                                                                                                                                                                                                                                                                1. Others
                                                                                                                                                                                                                                                                                                                2. Brazil Enzyme Replacement Therapy Market, By End-User
                                                                                                                                                                                                                                                                                                                  1. Hospitals
                                                                                                                                                                                                                                                                                                                    1. Infusion Centers and Home Healthcare Setting
                                                                                                                                                                                                                                                                                                                  2. Mexico
                                                                                                                                                                                                                                                                                                                  3. Argentina
                                                                                                                                                                                                                                                                                                                  4. Chile
                                                                                                                                                                                                                                                                                                                  5. Colombia
                                                                                                                                                                                                                                                                                                                  6. Rest of LATAM

                                                                                                                                                                                                                                                                                                              Related Reports

                                                                                                                                                                                                                                                                                                              Global Report
                                                                                                                                                                                                                                                                                                              The global hormone replacement therapy market size was valued at USD 31,060.5 million in 2021. It is expected to reach USD 55,973.9 million by 2030, growing at a CAGR of 5.5% during the forecast period (2022–2030). Hormone replacement therapy
                                                                                                                                                                                                                                                                                                              Buy Now
                                                                                                                                                                                                                                                                                                              Global Report
                                                                                                                                                                                                                                                                                                              The renal replacement therapy market size was valued at USD 923.4 million in 2019 and is expected to grow with a CAGR of 7.1%. Renal replacement therapy (RRT) is used to perform normal kidney functions and filter blood. Renal replacement therap
                                                                                                                                                                                                                                                                                                              Buy Now

                                                                                                                                                                                                                                                                                                              Purchase Benefits

                                                                                                                                                                                                                                                                                                              • Eligible for a free updated report next year
                                                                                                                                                                                                                                                                                                              • Completely customizable scope
                                                                                                                                                                                                                                                                                                              • 30% discount on your next purchase
                                                                                                                                                                                                                                                                                                              • Dedicated account manager
                                                                                                                                                                                                                                                                                                              • Query resolution within 24 hours
                                                                                                                                                                                                                                                                                                              • Permission to print the report

                                                                                                                                                                                                                                                                                                              We are featured on :

                                                                                                                                                                                                                                                                                                              www.straitsresearch.com
                                                                                                                                                                                                                                                                                                              © Copyright . All rights Reserved.